Article
- The EMBO Journal (2006) 25, 1456 - 1468
- doi:10.1038/sj.emboj.7601039
Published online: 16 March 2006
Subject Categories:
RNA-binding IMPs promote cell adhesion and invadopodia formation
Jonas Vikesaa1, Thomas VO Hansen1, Lars Jønson1, Rehannah Borup1, Ulla M Wewer2, Jan Christiansen3 and Finn C Nielsen1
- Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- Department of Molecular Pathology, University of Copenhagen, Copenhagen, Denmark
- Institute of Molecular Biology and Physiology, University of Copenhagen, Copenhagen, Denmark
Correspondence to:
Finn C Nielsen, Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark. Tel.: +45 3545 2223; Fax: +45 3545 4640; E-mail: fcn@rh.dk
Received 28 September 2005; Accepted 17 February 2006
Abstract
Oncofetal RNA-binding IMPs have been implicated in mRNA localization, nuclear export, turnover and translational control. To depict the cellular actions of IMPs, we performed a loss-of-function analysis, which showed that IMPs are necessary for proper cell adhesion, cytoplasmic spreading and invadopodia formation. Loss of IMPs was associated with a coordinate downregulation of mRNAs encoding extracellular matrix and adhesion proteins. The transcripts were present in IMP RNP granules, implying that IMPs were directly involved in the post-transcriptional control of the transcripts. In particular, we show that a 5.0 kb CD44 mRNA contained multiple IMP-binding sites in its 3'UTR, and following IMP depletion this species became unstable. Direct knockdown of the CD44 transcript mimicked the effect of IMPs on invadopodia, and we infer that CD44 mRNA stabilization may be involved in IMP-mediated invadopodia formation. Taken together, our results indicate that RNA-binding proteins exert profound effects on cellular adhesion and invasion during development and cancer formation.
Keywords:
- CD44,
- IMP,
- invadopodia,
- RNA-binding proteins,
- RNP granules
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Nature Letters to Editor (14 Apr 2005)
Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities
The EMBO Journal Article (09 Mar 2005)



